Gemcitabine and Platinol Followed by Pemetrexed and Gemcitabine in Patients With Advanced or Metastatic Bladder Cancer
Clinical trial NCT00101842 · COMPLETED
Trial details
- NCT number
- NCT00101842
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-12-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.